ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD/MASH

Published:2024-08 Issue: Volume: Page:
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Liu Yasmine J.^ORCID,Kimura Masaki,Li Xiaoxu^ORCID,Sulc Jonathan^ORCID,Wang Qi,Rodríguez-López Sandra^ORCID,Scantlebery Angelique M.L.^ORCID,Strotjohann Keno^ORCID,Gallart-Ayala Hector^ORCID,Vijayakumar Archana,Myers Robert P.,Ivanisevic Julijana,Houtkooper Riekelt H.,Subramanian G. Mani,Takebe Takanori,Auwerx Johan^ORCID

Funder

Horizon 2020 Framework Programme

European Molecular Biology Organization

National Research Foundation of Korea

Swiss National Science Foundation

BrightFocus Foundation

HORIZON EUROPE European Research Council

Office of Intramural Training and Education

Publisher

Elsevier BV

Reference44 articles.

1. The Epigenetic Drug Discovery Landscape for Metabolic-associated Fatty Liver Disease;Bayoumi;Trends Genet,2020

2. The genetics of NAFLD;Anstee;Nat Rev Gastroenterol Hepatol,2013

3. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention;Younossi;Nat Rev Gastroentero,2018

4. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

5. Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies;Sunny;Trends Endocrinol Metabolism,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP